SANA Investors Have Opportunity to Lead Sana Biotechnology, Inc. Securities Fraud Lawsuit
Provided By PR Newswire
Last update: May 12, 2025
NEW YORK, May 12, 2025 /PRNewswire/ --
Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Sana Biotechnology, Inc. (NASDAQ: SANA) between March 17, 2023 and November 4, 2024, both dates inclusive (the "Class Period"), of the important May 20, 2025 lead plaintiff deadline.
Read more at prnewswire.com3
+0.03 (+1.01%)
Find more stocks in the Stock Screener
SANA Latest News and Analysis
